Bilbao Auditorium (Hall 5)
Special symposium
Date
29.09.2019
Time
08:30 - 10:00
Location
Bilbao Auditorium (Hall 5)
Chairs
- Elena Garralda (Barcelona, Spain)
- Sabine C. Linn (Amsterdam, Netherlands)
Molecular tumour board: Where do we stand? What’s next?
Special symposium
Personalised oncogenomics: Is a precision approach necessary for every cancer or is there a therapy-driven bottleneck? (ID 123)
Lecture Time
08:30 - 08:50
Speakers
- David Huntsman (Vancouver, British Columbia, Canada)
Location
Bilbao Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
Molecular tumour board: Where do we stand? What’s next?
Special symposium
Building of a comprehensive clinical and molecular genomics database for patients with treatment-refractory cancers enrolled in clinical trials (ID 126)
Lecture Time
08:50 - 09:10
Speakers
- Philippe Bedard (Toronto, Ontario, Canada)
Location
Bilbao Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
Molecular tumour board: Where do we stand? What’s next?
Special symposium
Liquid biopsy for diagnostic and longitudinal tracking of metastatic patients (ID 125)
Lecture Time
09:10 - 09:30
Speakers
- Giulia Siravegna (Boston, MA, United States of America)
Location
Bilbao Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
Molecular tumour board: Where do we stand? What’s next?
Special symposium
Tissue and liquid biopsies with MTB for phase 1 trial selection: Experience in the TARGET trial (ID 124)
Lecture Time
09:30 - 09:50
Speakers
- Matthew G. Krebs (Manchester, United Kingdom)
Location
Bilbao Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
Molecular tumour board: Where do we stand? What’s next?
Special symposium
General discussion (ID 354)
Lecture Time
09:50 - 10:00
Location
Bilbao Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00